The rising interest in potent weight management has led to considerable exploration into cutting-edge treatments. Lately , Retatrutide, a dual -action GIP and glucagon-like peptide-1 (GLP-1) receptor agonist , has exhibited promising results in patient trials, implying potential for significant w